PATENT CLAIM ANALYSIS

Application Number: 16221390
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "378000"]

Abstract:
Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in need of treatment thereof an effective amount of an isoxazoline parasiticide, formamidine parasiticide, or other active ingredient, formulated into an ophthalmic composition, the ophthalmic composition further comprising a pharmaceutically acceptable vehicle. Compositions are also disclosed.

Claim (Index 11):
The method of  claim 10 , wherein the patient's eyes are closed upon topically administering the ophthalmic composition, such that the composition contacts orifices of Meibomian glands of the patient and outside of eyelid margins of the patient.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 98.0
- Lexical Diversity: 1.46552
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11846961', '13181767', '14133780', '13856638', '12771705']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7714956547559514
- 35 USC 102 Novelty (BERT): 0.5305967291733856
- Combined Prediction Score: 0.7474057621976948
- Mean Citation Score: 225.158708
- Max Citation Score: 237.24426
- Similarity Product: 166.08038284362317

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test